In people with long COVID, arterial stiffness in the large vessels looked no different from people who’d recovered cleanly.
The deficit sits one level down - in the smallest vessels, and specifically in how fast they can react.🧵
A new paper from Tübingen measured microvascular reactivity - how quickly a muscle re-oxygenates after its blood supply is cut off for a few minutes and then released. That re-flooding step is called reperfusion. A near-infrared sensor on a forearm muscle tracks how oxygenated the tissue is throughout.
29 patients with symptoms lasting more than 12 months after infection and a real impact on daily life, against 33 people who had the same infection and recovered without trouble. Everyone was infected in 2020–2021.
Reperfusion was slower in the patients (1.67 vs 2.23 %/s). Meanwhile large-artery stiffness, the ankle-brachial index, and resting values didn’t differ. So the deficit isn’t in the large arteries and isn’t about the resting state - it’s in the small vessels’ ability to dilate on demand.
The patients are less fit, so they perfuse worse. The authors expected that - the patients did have lower aerobic fitness (VO₂max). So they adjusted the reperfusion difference to subtract the effect of fitness. It survived. And it didn’t track with how much physical activity people reported.
Fitness is subtracted statistically, not physically, and activity was captured by a questionnaire with three-month recall. So the honest version - fitness doesn’t fully explain the deficit - not that it’s been proven unrelated to conditioning.
The patient group carried more cardiovascular risk and medication - a quarter were on anticoagulants, versus 3%. The authors admit they can’t tell whether that’s a consequence of COVID or something that predated it. Part of the measured gap could ride on that imbalance.
What might blunt that on-demand dilation?
Lower availability of nitric oxide (vasodilator released by the vessel lining), autoantibodies against vascular receptors, microclots, smoldering inflammation. None of these mechanisms were measured here
It slots into a growing pile of data on endothelial and microvascular dysfunction after COVID. And it fills in the exercise-intolerance picture. Other work has shown reduced oxygen extraction at the periphery and damaged mitochondria in muscle. This adds a middle link - the delivery of oxygen through the smallest vessels.
It’s a case-control study at a single time point. The sample is small and mildly underpowered.
One detail actually works in the finding’s favor. The controls had also been infected and could carry hidden vascular changes. That would tend to wash the difference out - so the real effect may be larger, not smaller.
In post-COVID exercise intolerance there’s an objective peripheral vascular limit you can measure right at the muscle. For rehab, the brake may be in how oxygen reaches the muscle in the first place.
Thiel at al., Impaired microvascular reactivity in post-COVID-19 syndrome is independent of cardiorespiratory fitness. journals.physiology.org/doi/full/10.11…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
New study in Journal of Sleep Research links long COVID to a higher burden of prodromal Parkinson's like features. 11,261 people, 16 countries.
The headline is weaker than it looks - but there is the one finding in this paper that should genuinely scare you, and almost nobody is quoting it 🧵
The main finding is mostly circular. The prodromal PD score is built from cognitive impairment, fatigue, depression, dysautonomia, anosmia, constipation. Those are long COVID. They renamed the long COVID symptom cluster prodromal PD and found long COVID predicts it.
Cognitive impairment carries OR 7.0 in their model. That's not a Parkinson's. That's brain fog wearing a different name tag.
Drop the six overlapping items and the effect barely moves aOR 1.73 - 1.66 because the overlap runs deeper than six items.
139 kids who'd had COVID. Half of them turned up with autoantibodies - antibodies that attack the body's own tissues. In uninfected kids, only 14%. And it barely mattered whether the child had been hospitalized with pneumonia or had next to no symptoms. 🧵
The study sorted the kids by how their infection went - mild/asymptomatic, severe COVID needing hospitalization, and MIS-C hyperinflammatory syndrome that shows up weeks after infection and hits several organs at once. Plus a group of healthy controls.
The kids were infected between June 2021 and November 2022 - Delta/Omicron era. The antibodies, meanwhile, were measured against the original Wuhan strain.
New study. In some people, a mild case of COVID seems to leave a hidden edit in how their cells manage their own RNA - and it doesn't fully reset once the virus is gone. Another possible clue to why some bodies don't bounce back the same. 🧵
Your DNA is the master copy. RNA is the working copy your cells actually read to build proteins. A family of enzymes called ADAR can edit letters in that working copy - swapping an A so it now reads as a G - without ever touching the DNA.
Why edit your own RNA? One crucial job - it stamps the cell's own double-stranded RNA as ours. Without that stamp, the immune system's virus sensors can mistake your own RNA for an invader and switch on inflammation.
Could the real trigger for Long COVID POTS be the immune system mistaking your own cells for the enemy? A new preprint makes the case that monocyte oxidative stress - not lingering virus - keeps the immune system switched on. Vanderbilt, 25 patients vs 15 recovered. 🧵
The headline finding.
Patients carry about 3× more doublets in their blood - T cells and monocytes stuck together. These used to get written off as a lab artifact. Turns out they're real, functional contacts where the cells are actively talking to each other. The body is working on something.
How do they know it's a real contact and not two cells bumping?
A technique called FRET, which measures whether two molecules are genuinely pressed together at the nanometer scale. The T cell's receptor and the molecule feeding it an antigen are sitting right on top of each other. That's a snapshot of active immune signaling, not coincidence.
Independent virus families - different genomes, life cycles, target tissues - keep ending up at the same two points in the brain. They switch on the same inflammation machinery, and they jam the cell's protein clean up system. If so, the damage is mostly the body's reaction, not the virus itself. 🧵
This is the core argument of a new review - one of the few that looks at post-viral brain symptoms through mechanisms shared across many viruses, instead of one virus at a time.
Why that's interesting?
The proteins come from completely unrelated viruses - COVID (the spike S1, N protein), the flaviviruses (dengue, West Nile, Japanese encephalitis), and influenza. Nothing about them predicts a shared effect on the brain - yet it shows up anyway.
A multi-omics paper on long COVID in Frontiers in Immunology deserves more attention than it got. The through-line is uncomfortable - the cellular power supply stays switched off long after the acute phase is over.🧵
It's an integration of existing public datasets under one roof. Syrian hamsters (muscle, heart, kidney, lung, 8 brain regions, out to 61 days post-infection) + human cohorts - immune cells, muscle biopsies, autopsy brain, and longitudinal serum stretching to 24 months. Different tissues, different species.
The recurring signal - suppressed OXPHOS - the mitochondrial machinery that makes ~90% of your ATP - paired with ongoing immune activation. Hamster or human. Heart or brain. Same story.